Want to see HK:8603 full AI Analyst Report?

Fameglow Holdings Limited (8603) Price & Analysis

0 Followers

8603 Stock Chart & Stats

HK$14.78

HK$0.50(3.62%)

At close: Jun 29 4:00 PM EDT

HK$14.78

HK$0.50(3.62%)

Day’s Range― - ―

52-Week RangeHK$1.55 - HK$19.50

Previous CloseN/A

Volume101.00K

Average Volume (3M)238.30K

Market Cap

HK$12.09B

Enterprise ValueHK$9.25B

Total Cash (Recent Filing)HK$110.69M

Total Debt (Recent Filing)HK$119.18M

Price to Earnings (P/E)114.3

Beta0.03

Next Earnings

Nov 17, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.09

Shares Outstanding818,920,000

10 Day Avg. Volume318,900

30 Day Avg. Volume238,300

Financial Highlights & Ratios

PEG Ratio4.90

Price to Book (P/B)23.98

Price to Sales (P/S)8.42

P/FCF Ratio110.16

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Revenue Growth & ScaleStrong multi‑year revenue growth from 2023–2026 indicates expanding market penetration and effective product/channel execution. Durable topline gains support operating leverage and scale benefits, providing runway for reinvestment and sustaining business momentum over the next several months.

Improving ProfitabilityThe company reports healthy trailing‑twelve‑month gross (~37%) and net (~9%) margins with positive EBIT and EBITDA, reflecting a durable turnaround from prior losses. Sustained profitability strengthens cash generation potential and strategic flexibility for reinvestment or debt reduction over the medium term.

Balance Sheet DeleveragingLeverage reduction through 2026 has moved debt to a more manageable level relative to assets and equity. A healthier capital structure lowers refinancing risk, increases resilience to shocks, and gives management more optionality for capital allocation and investment over the coming months.

Bears Say

Margin CompressionReported margin compression versus 2023–2025 signals rising input costs or adverse product/mix shifts as the business scales. If persistent, this trend could erode recent profitability improvements, reduce free cash flow and constrain strategic choices over a 2–6 month horizon.

Weak Cash ConversionTTM free cash flow at roughly 40% of net income indicates weak cash conversion, likely driven by working‑capital requirements or reinvestment. Low conversion limits the firm’s ability to fund growth internally, accelerate debt paydown, or return cash to shareholders sustainably.

Historic Leverage VolatilityA prior history of very high leverage and thin equity highlights capital‑structure volatility. Should profitability deteriorate, the company could face renewed balance‑sheet stress, tighter financing conditions or limited strategic flexibility within a medium‑term timeframe.

8603 FAQ

What was Fameglow Holdings Limited’s price range in the past 12 months?

Fameglow Holdings Limited lowest stock price was HK$1.55 and its highest was HK$19.50 in the past 12 months.

What is Fameglow Holdings Limited’s market cap?

Fameglow Holdings Limited’s market cap is HK$12.09B.

When is Fameglow Holdings Limited’s upcoming earnings report date?

Fameglow Holdings Limited’s upcoming earnings report date is Nov 17, 2026 which is in 93 days.

How were Fameglow Holdings Limited’s earnings last quarter?

Fameglow Holdings Limited released its earnings results on May 15, 2026. The company reported HK$0.042 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.042.

Is Fameglow Holdings Limited overvalued?

According to Wall Street analysts Fameglow Holdings Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Fameglow Holdings Limited pay dividends?

Fameglow Holdings Limited does not currently pay dividends.

What is Fameglow Holdings Limited’s EPS estimate?

Fameglow Holdings Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Fameglow Holdings Limited have?

Fameglow Holdings Limited has 818,920,000 shares outstanding.

What happened to Fameglow Holdings Limited’s price movement after its last earnings report?

Fameglow Holdings Limited reported an EPS of HK$0.042 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.193%.

Which hedge fund is a major shareholder of Fameglow Holdings Limited?

Currently, no hedge funds are holding shares in HK:8603

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Fameglow Holdings Limited Stock Smart Score

Outperform

Technicals

Fundamentals

Return on Equity

―

Trailing 12-Months

Asset Growth

38.54%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Fameglow Holdings Limited

Fameglow Holdings Limited, an investment holding entity, offers a range of non-surgical medical aesthetic services across Hong Kong. These include energy-based procedures, which employ various devices that emit energy onto the skin's surface, and minimally invasive treatments such as injections, characterized by minimal tissue penetration without surgical incisions. The company also provides traditional non-medical and non-invasive beauty services. Additionally, Fameglow sells skincare products through its retail outlets and sales counters, and holds property investments. Its medical aesthetic centers operate under the "per Face" brand, situated in prominent locations like Causeway Bay, Mong Kok, Tsim Sha Tsui, and Central. Founded in 2008, the company is headquartered in Cheung Sha Wan, Hong Kong, and functions as a subsidiary of Equal Joy Holdings Limited.